Drug Research
Drug Discovery & Development

Drug Discovery & Development News

View news from other Pharmaceutical sectors:
181-195 of 4721 results
Fate Therapeutics, University of California San Diego launch CAR NK Cancer immunotherapy collaboration
Fate Therapeutics has partnered with the University of California San Diego to develop off-the-shelf, chimeric antigen receptor (CAR)-targeted natural killer (NK) cell cancer immunotherapies.
Drug Research > Drug Discovery & Development > News
Carmot, Amgen form drug discovery partnership
Carmot Therapeutics has entered into a multi-year drug discovery collaboration and licensing agreement with Amgen. The collaboration intends to identify novel molecules aimed for Parkinson’s disease.
Drug Research > Drug Discovery & Development > News
Researchers show aspirin added to cancer drug improves effectiveness
Adding aspirin to some existing cancer drugs could increase their effectiveness against a group of tumours resistant to treatment, new research has shown.
Drug Research > Drug Discovery & Development > News
Blue Oak, PsychoGenics enter into drug discovery partnership
Blue Oak Pharmaceuticals and PGI Drug Discovery (PsychoGenics) have entered into a partnership to discover and optimize novel treatments for brain disorders and psychiatric conditions.
Drug Research > Drug Discovery & Development > News
Astellas Pharma acquires Mitobridge for $225m
Astellas Pharma has exercised its exclusive option right to acquire Mitobridge under the amended terms of the October 2013 partnership agreement governing their research and development (R&D) collaboration focused on discovering and developing novel drugs that target mitochondrial function.
Drug Research > Drug Discovery & Development > News
I-Mab Biopharma partners with MorphoSys on cancer investigational medicine
I-Mab Biopharma and MorphoSys have entered into an exclusive regional licensing agreement to develop and commercialize MOR202 in China, Taiwan, Hong Kong and Macao.
Drug Research > Drug Discovery & Development > News
resTORbio raises $40m from biotech and institutional investors
resTORbio, a clinical-stage biopharmaceutical company engaged in the development and commercialization of novel therapeutics for the treatment of aging-related diseases, has raised $40m in a Series B financing round.
Drug Research > Drug Discovery & Development > News
Biogen, Alkermes to develop and commercialize ALKS 8700 to treat multiple sclerosis
Biogen and Alkermes have entered into a global license and collaboration agreement to develop and commercialize ALKS 8700, a novel, oral, monomethyl fumarate (MMF) small drug molecule in phase 3 development for the treatment of relapsing forms of multiple sclerosis (MS).
Drug Research > Drug Discovery & Development > News
MSD to establish life sciences discovery research facility in London
By PBR Staff Writer
MSD, known as Merck and co. in North America, has unveiled plans to establish a life sciences discovery research facility in London, UK, creating around 950 jobs.
Drug Research > Drug Discovery & Development > News
PhoenixBio invests in KMT Hepatech
KMT Hepatech has reached an agreement to join efforts with PhoenixBio. Together the companies will advance the use of the cDNA-uPA/SCID mouse model with highly humanized liver to support researchers across a range of drug development fields.
Drug Research > Drug Discovery & Development > News
Research finds gastric acid suppressant lansoprazole could target tuberculosis
By PBR Staff Writer
A new research in the UK suggests that a cheap and commonly used drug to treat heartburn, gastritis and ulcers has the potential to target Mycobacterium tuberculosis, the bacteria that causes tuberculosis (TB).
Drug Research > Drug Discovery & Development > News
Hemogenyx, University of Oxford partner to transform blood cancers treatment
Hemogenyx Pharmaceuticals has partnered the University of Oxford to test new means of accelerating and improving the process by which transplanted blood stem cells grow and make healthy blood cells.
Drug Research > Drug Discovery & Development > News
Canadian researchers discover medication to treat amyotrophic lateral sclerosis
By PBR Staff Writer
Canadian researchers have discovered an effective medication for the treatment of individuals with amyotrophic lateral sclerosis (ALS) or Lou Gehrig’s disease.
Drug Research > Drug Discovery & Development > News
Can-Fite’s former subsidiary OphthaliX merges with Wize Pharma
Can-Fite BioPharma says that its previously majority owned subsidiary OphthaliX has completed a merger with Wize Pharma.
Drug Research > Drug Discovery & Development > News
Inozyme Pharma secures $49m funding for rare disease therapies
Inozyme Pharma, which is developing novel medicines to treat rare diseases of calcification, affecting soft tissues and bone, has raised a $49m Series A financing.
Drug Research > Drug Discovery & Development > News
181-195 of 4721 results